| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.47B | 67.72B | 88.47B | 79.06B | 72.58B | 59.51B |
| Gross Profit | 10.14B | 9.01B | 10.60B | 9.30B | 8.58B | 8.40B |
| EBITDA | 5.59B | 4.68B | 6.09B | 5.21B | 4.35B | 4.93B |
| Net Income | 2.96B | 2.90B | 2.96B | 2.12B | 1.23B | 2.75B |
Balance Sheet | ||||||
| Total Assets | 95.27B | 108.08B | 107.47B | 108.51B | 102.98B | 89.62B |
| Cash, Cash Equivalents and Short-Term Investments | 8.43B | 7.77B | 12.30B | 13.26B | 10.09B | 23.30B |
| Total Debt | 9.30B | 19.62B | 6.95B | 9.19B | 8.65B | 1.83B |
| Total Liabilities | 26.49B | 39.65B | 38.93B | 42.58B | 38.51B | 24.75B |
| Stockholders Equity | 68.77B | 68.43B | 68.55B | 66.26B | 64.63B | 64.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -15.99B | 7.57B | 4.19B | -12.02B | 7.35B |
| Operating Cash Flow | 0.00 | -15.23B | 8.50B | 8.14B | -5.73B | 10.75B |
| Investing Cash Flow | 0.00 | -90.00M | -5.13B | -3.12B | -385.00M | -16.16B |
| Financing Cash Flow | 0.00 | 10.65B | -4.45B | -656.00M | 5.78B | 469.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥259.31B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
76 Outperform | ¥42.38B | 7.43 | 7.09% | 3.06% | -5.41% | 5.68% | |
76 Outperform | ¥96.56B | 13.41 | ― | 4.38% | -0.84% | -1.80% | |
72 Outperform | ¥1.29T | 12.95 | 14.94% | 2.00% | 16.43% | 53.76% | |
72 Outperform | ¥699.53B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥54.87B | 11.64 | ― | 2.95% | -7.98% | 37.92% |